Latest News and Press Releases

RALEIGH, N.C., July 30, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a leading commercial based specialty pharmaceutical company focused on patients living with...

BOISE, ID, June 26, 2018 (GLOBE NEWSWIRE) -- Albertsons Companies announced today that more than 1,600 of its pharmacies across 21 states have pharmacists with the ability to independently provide...

PHOENIX, June 18, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology,...

RALEIGH, N.C., June 01, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (NASDAQ:BDSI), a leading specialty pharmaceutical company in the field of pain management and addiction...

RALEIGH, N.C., May 23, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (NASDAQ:BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine,...

SAN DIEGO, May 21, 2018 (GLOBE NEWSWIRE) -- Suboxone is a newly approved drug that combats the painful and difficult disease of addiction.  One of many drugs used particularly for heroin and opioid...

SAN DIEGO, May 21, 2018 (GLOBE NEWSWIRE) -- Suboxone is a prescription drug that is used to help with opiate dependencies. Some of the most common opioids are heroin and morphine. The reason why...

SAN DIEGO, May 21, 2018 (GLOBE NEWSWIRE) -- Suboxone is a leading opioid replacement medication that combines buprenorphine and naloxone into a modest-sized tablet or thin film that is dissolved...

BELBUCA® Net Revenues Increased 76% Over 1Q17Achieved Significant Prescription Growth Increase of 55% for BELBUCA in 1Q18 vs 1Q17  Achieved Company Total Net Revenue of $11.3 Million for 1Q18Addition...

Cannabinoid and spray-technology focused pipeline continues to advance, while efforts to stabilize SUBSYS® revenue continue PHOENIX, May 08, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc....